Related Experiment Videos
Ki-ras point mutations and proliferation activity in biliary tract carcinomas
K Ohashi1, M Tstsumi, Y Nakajima
1First Department of Surgery, Nara Medical University, Japan.
British Journal of Cancer
|September 1, 1996
Summary
This study reveals frequent Ki-ras mutations in biliary tract carcinomas (BTCs), particularly in gallbladder carcinomas (GBCs) and distal extrahepatic cholangiocarcinomas (ECCs). Tumors with these mutations exhibit significantly higher cell proliferation activity.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Biliary tract carcinomas (BTCs) are a heterogeneous group of cancers with varying prognoses.
- The role of specific gene mutations, such as Ki-ras, in BTC development and progression is an area of active research.
- Understanding the association between genetic alterations and tumor behavior, like proliferation, is crucial for targeted therapies.
Purpose of the Study:
- To investigate the frequency of Ki-ras mutations in different subtypes of biliary tract carcinomas (BTCs).
- To determine the correlation between Ki-ras mutations and tumor proliferation activity, assessed by proliferating cell nuclear antigen labelling index (PCNA LI).
- To identify specific BTC subtypes where Ki-ras mutations are most prevalent.
Main Methods:
- Microdissection of paraffin-embedded tissue samples from 77 BTCs (intrahepatic cholangiocarcinomas (ICCs), extrahepatic cholangiocarcinomas (ECCs), and gall bladder carcinomas (GBCs)).
- Detection of Ki-ras mutations in exons 1 and 2 using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) and direct sequencing.
- Immunohistochemical assessment of proliferation activity using proliferating cell nuclear antigen (PCNA) labelling indices (LIs).
Main Results:
- Ki-ras mutations were detected in 45% of ICCs, 67% of ECCs, and 84% of GBCs.
- Mutation frequency varied within ICCs (33% peripheral, 60% hilar) and ECCs (82% in lower biliary tree).
- Mean PCNA LI was significantly higher in mutation-positive BTCs compared to mutation-negative ones.
Conclusions:
- Ki-ras mutations are frequently involved in the pathogenesis of BTCs, with a notably high prevalence in GBCs and distal ECCs.
- The presence of Ki-ras mutations is strongly associated with increased cell proliferation activity in BTCs.
- These findings highlight the importance of Ki-ras mutational status in understanding BTC biology and may inform future therapeutic strategies.